Paul Hastings

Insider profile

Currently holds positions in Protara Therapeutics Inc and Pacira Biosciences Inc

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Protara Therapeutics Inc Jan. 1, 2017 -
Lead Independent Director Pacira Biosciences Inc June 1, 2013 -
Chairman of the Board, Chief Executive Officer OncoMed Pharmaceuticals Inc Sept. 18, 2017 - Jan. 1, 2018
Chairman of the Board, President, Chief Executive Officer OncoMed Pharmaceuticals Inc Jan. 1, 2014 - Sept. 18, 2017
Chairman of the Board Protara Therapeutics Inc Oct. 18, 2016 - Jan. 1, 2017
President, Chief Executive Officer and Board Member OncoMed Pharmaceuticals Inc None -
Independent Director Pacira Biosciences Inc June 2, 2011 - June 1, 2013

Paul Hastings's trades of Nkarta Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-22 2026-06-18 PlS Planned sale
73,215 -23.6%
84.86
US$3,753,716
73,215 -23.6% 84.86 US$3,753,716
2026-06-22 2026-06-18 PlS Planned sale
39,873 +45.7%
221.16
US$1,460,778
39,873 +45.7% 221.16 US$1,460,778
2026-01-20 2026-01-15 S Sale
35,709 -20.0%
110.35
US$3,806,429
35,709 -20.0% 110.35 US$3,806,429
2025-06-20 2025-06-18 PlS Planned sale
1,790 -0.6%
1.79
US$3,204
1,790 -0.6% 1.79 US$3,204
2025-01-17 2025-01-15 S Sale
17,378 -5.2%
2.20
US$38,232
17,378 -5.2% 2.20 US$38,232
2024-06-20 2024-06-18 S Sale
1,770 -0.7%
5.60
US$9,912
1,770 -0.7% 5.60 US$9,912
2024-06-13 2024-06-13 PrS Proposed sale
880
28.38
US$24,974
880 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
880 -6.5%
28.38
US$24,974
880 -6.5% 28.38 US$24,974
2024-03-04 2024-03-04 PrS Proposed sale
60,000
12.84
US$770,400
60,000 12.84 US$770,400
2024-03-01 2024-03-01 PrS Proposed sale
120,000
12.08
US$1,449,600
120,000 12.08 US$1,449,600
2024-01-18 2024-01-16 S Sale
9,697 -2.4%
8.74
US$84,752
9,697 -2.4% 8.74 US$84,752
2023-06-22 2023-06-20 PlS Planned sale
1,704 -0.5%
4.85
US$8,264
1,704 -0.5% 4.85 US$8,264
2023-06-07 2023-06-05 S Sale
580 -8.1%
38.34
US$22,237
580 -8.1% 38.34 US$22,237
2023-06-05 2023-06-05 PrS Proposed sale
580
38.34
US$22,236
580 38.34 US$22,236
2023-05-17 2023-05-15 PlS Planned sale
7,000 -49.4%
41.85
US$292,950
7,000 -49.4% 41.85 US$292,950
2023-05-15 2023-05-15 PrS Proposed sale
7,000
41.85
US$292,950
7,000 41.85 US$292,950
2023-01-18 2023-01-17 PlS Planned sale
3,691 -1.2%
5.49
US$20,264
3,691 -1.2% 5.49 US$20,264
2022-09-22 2022-09-21 PlS Planned sale
6,126 -2.2%
13.01
US$79,717
6,126 -2.2% 13.01 US$79,717
2022-07-13 2022-07-11 PlS Planned sale
533 -6.9%
56.95
US$30,354
533 -6.9% 56.95 US$30,354
2021-10-01 2021-09-29 PlS Planned sale
223 -0.1%
26.53
US$5,916
223 -0.1% 26.53 US$5,916
2021-10-01 2021-09-29 PlS Planned sale
8,277 -3.6%
27.20
US$225,134
8,277 -3.6% 27.20 US$225,134
2021-06-23 2021-06-21 PlS Planned sale
3,807 -1.6%
26.89
US$102,370
3,807 -1.6% 26.89 US$102,370
2021-06-23 2021-06-21 PlS Planned sale
4,693 -2.0%
26.39
US$123,848
4,693 -2.0% 26.39 US$123,848
2021-06-08 2021-06-04 PlS Planned sale
630 -10.3%
62.19
US$39,180
630 -10.3% 62.19 US$39,180
2021-04-01 2021-03-30 PlS Planned sale
3,130 -1.3%
32.21
US$100,817
3,130 -1.3% 32.21 US$100,817
2021-04-01 2021-03-30 PlS Planned sale
2,409 -1.0%
31.24
US$75,257
2,409 -1.0% 31.24 US$75,257
2021-04-01 2021-03-30 PlS Planned sale
11,461 -4.5%
30.23
US$346,466
11,461 -4.5% 30.23 US$346,466
2021-03-09 2021-03-05 S Sale
3,000 -32.9%
65.88
US$197,640
3,000 -32.9% 65.88 US$197,640
2020-06-08 2020-06-04 S Sale
2,025 -29.4%
47.46
US$96,106
2,025 -29.4% 47.46 US$96,106
2019-06-06 2019-06-04 PlS Planned sale
782 -22.2%
42.66
US$33,360
782 -22.2% 42.66 US$33,360
2017-10-12 2017-10-10 S Sale
52 -0.1%
4.26
US$222
52 -0.1% 4.26 US$222
2016-06-08 2016-06-06 PlS Planned sale
1,136 -39.8%
46.95
US$53,335
1,136 -39.8% 46.95 US$53,335
2016-01-08 2016-01-06 PlS Planned sale
2,335 -9.6%
22.30
US$52,072
2,335 -9.6% 22.30 US$52,072